Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre S Rohrlich

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Blood|July 21, 2018
The cells are ambiguous, not the messagePierre S Rohrlich
British Journal of Haematology|April 23, 2014
Malignancy and thrombotic microangiopathy or atypical haemolytic and uraemic syndrome?Guillaume A Favre, Maxime Touzot, Véronique Fremeaux-Bacchi, et al.
European Journal of Immunology|April 26, 2012
Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosisRachid Boucherma, Hédia Kridane-Miledi, Francina Langa Vives, et al.
Cancers|May 11, 2024
Identifying Candidate Gene Drivers Associated with Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia Using a Gene Co-Expression Network ApproachAnthony Kypraios, Juba Bennour, Véronique Imbert, et al.
Blood|July 21, 2010
Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targetsAndrew D Hislop, Umaimainthan Palendira, Alison M Leese, et al.
Human Immunology|June 3, 2004
Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cellsPierre S Rohrlich, Sylvain Cardinaud, Jacqueline Lulè, et al.
Haematologica|July 1, 2021
Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemiaLisa M Niswander, Joseph P Loftus, Élodie Lainey, et al.
Blood|July 16, 2011
Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantationFabrice Larosa, Eric Deconinck, Philippe Helias, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2005
Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting functionPierre S Rohrlich, Nicolas Fazilleau, Florent Ginhoux, et al.
Annals of Hematology|October 13, 2015
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trialsPauline Simon, Stefan Suciu, Emmanuelle Clappier, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Blood|July 21, 2018
The cells are ambiguous, not the messagePierre S Rohrlich
British Journal of Haematology|April 23, 2014
Malignancy and thrombotic microangiopathy or atypical haemolytic and uraemic syndrome?Guillaume A Favre, Maxime Touzot, Véronique Fremeaux-Bacchi, et al.
European Journal of Immunology|April 26, 2012
Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosisRachid Boucherma, Hédia Kridane-Miledi, Francina Langa Vives, et al.
Cancers|May 11, 2024
Identifying Candidate Gene Drivers Associated with Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia Using a Gene Co-Expression Network ApproachAnthony Kypraios, Juba Bennour, Véronique Imbert, et al.
Blood|July 21, 2010
Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targetsAndrew D Hislop, Umaimainthan Palendira, Alison M Leese, et al.
Human Immunology|June 3, 2004
Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cellsPierre S Rohrlich, Sylvain Cardinaud, Jacqueline Lulè, et al.
Haematologica|July 1, 2021
Therapeutic potential of ruxolitinib and ponatinib in patients with <i>EPOR</i>-rearranged Philadelphia chromosome-like acute lymphoblastic leukemiaLisa M Niswander, Joseph P Loftus, Élodie Lainey, et al.
Blood|July 16, 2011
Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantationFabrice Larosa, Eric Deconinck, Philippe Helias, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2005
Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting functionPierre S Rohrlich, Nicolas Fazilleau, Florent Ginhoux, et al.
Annals of Hematology|October 13, 2015
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trialsPauline Simon, Stefan Suciu, Emmanuelle Clappier, et al.
Pageof 2